OR WAIT null SECS
January 2015, 2016.
The European injectable drug delivery market is expected to reach $207.3 billion by 2020 from $114.7 billion in 2015, according a report from Reportlinker.
The report identifies factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements as driving the growth of the market. In addition, it states, Europe is emphasizing innovation of formulations and improving the delivery of pharmaceuticals with projects such as the COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets) consortium funded by the Innovative Medicines Initiative (IMI).
Germany is expected to be the fastest-growing country in the European injectable drug delivery market, with high growth attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.